S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 13.51 CNY 4.24%
Market Cap: 8.9B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Shandong Sinobioway Biomedicine Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shandong Sinobioway Biomedicine Co Ltd
Total Equity Peer Comparison

Comparables:
546
G
9933
600989
600596
A
002597

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Total Equity
ÂĄ2B
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
11%
Fufeng Group Ltd
HKEX:546
Total Equity
ÂĄ17.5B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
N/A
G
GHW International
HKEX:9933
Total Equity
ÂĄ581.4m
CAGR 3-Years
41%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
Total Equity
ÂĄ40B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
Total Equity
ÂĄ12.7B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
11%
A
Anhui Jinhe Industrial Co Ltd
SZSE:002597
Total Equity
ÂĄ7.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Shandong Sinobioway Biomedicine Co Ltd's Total Equity?
Total Equity
2B CNY

Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Total Equity amounts to 2B CNY.

What is Shandong Sinobioway Biomedicine Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
11%

Over the last year, the Total Equity growth was -12%. The average annual Total Equity growth rates for Shandong Sinobioway Biomedicine Co Ltd have been -3% over the past three years , -6% over the past five years , and 11% over the past ten years .

Back to Top